哮喘日记在住院患者干粉吸入剂中的临床应用
Journal: Clinical Application Research of Nursing Care DOI: 10.12238/carnc.v3i2.13343
Abstract
目的：探讨哮喘日记在住院患者干粉吸入剂治疗中的临床应用。[方法]将90名哮喘患者随机分成观察组（n=44）和对照组（n=46），对照组接受常规的干粉吸入剂治疗，观察组在此基础上使用哮喘日记进行记录，对两组的干粉吸入剂临床治疗效果、患者第1秒用力呼气容积(FEV1)、第1秒用力呼气容积占预计值的百分比(FEV1%pred)和呼气高峰流量(PEFR)及哮喘发作与就医情况进行比较。[结果]以哮喘日记为个体化的治疗效果优于传统的治疗，差异有统计学意义（P＜0.05）。[结论]哮喘日记有利于干粉吸入剂住院患者的治疗。
Keywords
哮喘日记；干粉吸入剂；住院患者；临床应用
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
[1] Qi, Jian-Hong et al. “Micro-simulation insights into the functional and mechanistic understanding of glycyrrhizin against asthma.” Frontiers in pharmacology vol. 14 1220368. 28 Aug. 2023, doi:10.3389/fphar.2023.1220368
[2] Tian, Jiayu et al. “Sestrin2/Keap1/Nrf2 pathway regulates mucus hypersecretion in pulmonary epithelium induced by traffic-related PM2.5 and water-soluble extracts.” Ecotoxicology and environmental safety, vol. 264 115455. 11 Sep. 2023, doi:10.1016/j.ecoenv.2023.115455
[3] Albanna, Amr S et al. “The impact of unsupervised and unconsented switch of inhalers in patients with controlled asthma - A targeted literature review.” Annals of thoracic medicine vol. 18,3 (2023): 103-115. doi:10.4103/atm.atm_438_22
[4] Baker, Jillian G, and Dominick E Shaw. “Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.” Handbook of experimental pharmacology, 10.1007/164_2023_679. 15 Sep. 2023, doi:10.1007/164_2023_679
[5] Yasaratne, Duminda et al. “Asthma in developing countries in the Asia-Pacific Region (APR).” Respirology (Carlton, Vic.), 10.1111/resp.14590. 13 Sep. 2023, doi:10.1111/resp.14590
[6] Ma, Yunlei et al. “Ozone Pollution and Acute Exacerbation of Asthma in Residents of China: An Ecological Study.” Journal of asthma and allergy vol. 16 951-960. 6 Sep. 2023, doi:10.2147/JAA.S422476
[7] 张秋菊.分析支气管哮喘的致病因素以及相应处理措施[J].世界最新医学信息文摘,2016,16(35):7-8.
[8] Çakmaklı, Seçil et al. “An evaluation of the use of inhalers in asthma and chronic obstructive pulmonary disease.” Journal of Taibah University Medical Sciences vol. 18,4 860-867. 12 Jan. 2023, doi:10.1016/j.jtumed.2023.01.001
[9] Gaikwad, Sachin S et al. “Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies.” Journal of controlled release : official journal of the Controlled Release Society vol. 355 (2023): 292-311. doi:10.1016/j.jconrel.2023.01.083
[2] Tian, Jiayu et al. “Sestrin2/Keap1/Nrf2 pathway regulates mucus hypersecretion in pulmonary epithelium induced by traffic-related PM2.5 and water-soluble extracts.” Ecotoxicology and environmental safety, vol. 264 115455. 11 Sep. 2023, doi:10.1016/j.ecoenv.2023.115455
[3] Albanna, Amr S et al. “The impact of unsupervised and unconsented switch of inhalers in patients with controlled asthma - A targeted literature review.” Annals of thoracic medicine vol. 18,3 (2023): 103-115. doi:10.4103/atm.atm_438_22
[4] Baker, Jillian G, and Dominick E Shaw. “Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.” Handbook of experimental pharmacology, 10.1007/164_2023_679. 15 Sep. 2023, doi:10.1007/164_2023_679
[5] Yasaratne, Duminda et al. “Asthma in developing countries in the Asia-Pacific Region (APR).” Respirology (Carlton, Vic.), 10.1111/resp.14590. 13 Sep. 2023, doi:10.1111/resp.14590
[6] Ma, Yunlei et al. “Ozone Pollution and Acute Exacerbation of Asthma in Residents of China: An Ecological Study.” Journal of asthma and allergy vol. 16 951-960. 6 Sep. 2023, doi:10.2147/JAA.S422476
[7] 张秋菊.分析支气管哮喘的致病因素以及相应处理措施[J].世界最新医学信息文摘,2016,16(35):7-8.
[8] Çakmaklı, Seçil et al. “An evaluation of the use of inhalers in asthma and chronic obstructive pulmonary disease.” Journal of Taibah University Medical Sciences vol. 18,4 860-867. 12 Jan. 2023, doi:10.1016/j.jtumed.2023.01.001
[9] Gaikwad, Sachin S et al. “Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies.” Journal of controlled release : official journal of the Controlled Release Society vol. 355 (2023): 292-311. doi:10.1016/j.jconrel.2023.01.083
Copyright © 2025 赵娜, 黄湘琳
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
